165 related articles for article (PubMed ID: 2164608)
1. O glycosylation of glycoprotein G of human respiratory syncytial virus is specified within the divergent ectodomain.
Collins PL
J Virol; 1990 Aug; 64(8):4007-12. PubMed ID: 2164608
[TBL] [Abstract][Full Text] [Related]
2. Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus.
Olmsted RA; Murphy BR; Lawrence LA; Elango N; Moss B; Collins PL
J Virol; 1989 Jan; 63(1):411-20. PubMed ID: 2535742
[TBL] [Abstract][Full Text] [Related]
3. Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation.
Wertz GW; Krieger M; Ball LA
J Virol; 1989 Nov; 63(11):4767-76. PubMed ID: 2677404
[TBL] [Abstract][Full Text] [Related]
4. Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus.
Sullender W
Virology; 1995 May; 209(1):70-9. PubMed ID: 7747486
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
[TBL] [Abstract][Full Text] [Related]
6. Intracellular processing and transport of NH2-terminally truncated forms of a hemagglutinin-neuraminidase type II glycoprotein.
Spriggs MK; Collins PL
J Cell Biol; 1990 Jul; 111(1):31-44. PubMed ID: 2164031
[TBL] [Abstract][Full Text] [Related]
7. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses.
Sullender WM; Mufson MA; Anderson LJ; Wertz GW
J Virol; 1991 Oct; 65(10):5425-34. PubMed ID: 1895391
[TBL] [Abstract][Full Text] [Related]
8. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
[TBL] [Abstract][Full Text] [Related]
9. Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1.
Tao T; Durbin AP; Whitehead SS; Davoodi F; Collins PL; Murphy BR
J Virol; 1998 Apr; 72(4):2955-61. PubMed ID: 9525616
[TBL] [Abstract][Full Text] [Related]
10. Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A.
Collins PL; Mottet G
J Gen Virol; 1992 Apr; 73 ( Pt 4)():849-63. PubMed ID: 1634876
[TBL] [Abstract][Full Text] [Related]
11. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
[TBL] [Abstract][Full Text] [Related]
12. Functional chimeric HN glycoproteins derived from Newcastle disease virus and human parainfluenza virus-3.
Deng R; Mirza AM; Mahon PJ; Iorio RM
Arch Virol Suppl; 1997; 13():115-30. PubMed ID: 9413532
[TBL] [Abstract][Full Text] [Related]
13. Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein.
Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang Z
Virus Res; 2013 Jun; 174(1-2):137-47. PubMed ID: 23562646
[TBL] [Abstract][Full Text] [Related]
14. Defective assembly and intracellular transport of mutant paramyxovirus hemagglutinin-neuraminidase proteins containing altered cytoplasmic domains.
Parks GD; Lamb RA
J Virol; 1990 Aug; 64(8):3605-16. PubMed ID: 2164588
[TBL] [Abstract][Full Text] [Related]
15. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
Anderson K; Stott EJ; Wertz GW
J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
[TBL] [Abstract][Full Text] [Related]
16. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
MartÃnez I; Dopazo J; Melero JA
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2419-29. PubMed ID: 9349460
[TBL] [Abstract][Full Text] [Related]
17. Sequence comparison of the phosphoprotein mRNAs of antigenic subgroups A and B of human respiratory syncytial virus identifies a highly divergent domain in the predicted protein.
Johnson PR; Collins PL
J Gen Virol; 1990 Feb; 71 ( Pt 2)():481-5. PubMed ID: 2307966
[TBL] [Abstract][Full Text] [Related]
18. Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses.
Anderson K; King AM; Lerch RA; Wertz GW
Virology; 1992 Nov; 191(1):417-30. PubMed ID: 1413513
[TBL] [Abstract][Full Text] [Related]
19. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.
Sullender WM; Edwards KG
Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149
[TBL] [Abstract][Full Text] [Related]
20. Role of a conserved sequence in the maturation and function of the NDV HN glycoprotein.
Sergel T; McGinnes L; Morrison T
Virus Res; 1993 Dec; 30(3):281-94. PubMed ID: 8109161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
